Flu Vaccine (Influenza Vaccine) Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
Flu Vaccine (Influenza Vaccine) Market Size, COVID-19 Impact Analysis By Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2028 (Updated Version Available)
ID : MRI16202 | Date : Jan, 2021 | Pages :
186 | Region : Global |
Publisher : RI
The Flu Vaccine (Influenza Vaccine) market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Flu Vaccine (Influenza Vaccine) market size is expected to gain market growth in the forecast period of 2020 to 2028, with a CAGR of xx%% in the forecast period of 2020 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
By Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Competitive Landscape and Flu Vaccine (Influenza Vaccine) Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Flu Vaccine (Influenza Vaccine) competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Flu Vaccine (Influenza Vaccine) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Flu Vaccine (Influenza Vaccine) sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Flu Vaccine (Influenza Vaccine) market presented in the report. This section sheds light on the sales growth of different regional and country-level Flu Vaccine (Influenza Vaccine) markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Flu Vaccine (Influenza Vaccine) market.
Region Coverage (Regional Production, Demand & Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Flu Vaccine (Influenza Vaccine) market for the forecast period 2020 - 2028?
• What are the driving forces in the Flu Vaccine (Influenza Vaccine) market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Flu Vaccine (Influenza Vaccine) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Table of Contents
1 Study Coverage
1.1 Flu Vaccine (Influenza Vaccine) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by Product
1.4.2 Whole Virus Vaccines
1.4.3 Split Virus Vaccines
1.4.4 Subunit Vaccines
1.4.5 Live Attenuated Virus Vaccines
1.5 Market by End User
1.5.1 Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by End User
1.5.2 For Children (6 months to 3 years)
1.5.3 For Adults and Children over 3 years
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Flu Vaccine (Influenza Vaccine) Market Size
2.1.1 Global Flu Vaccine (Influenza Vaccine) Revenue 2015-2028
2.1.2 Global Flu Vaccine (Influenza Vaccine) Sales 2015-2028
2.2 Flu Vaccine (Influenza Vaccine) Growth Rate by Regions
2.2.1 Global Flu Vaccine (Influenza Vaccine) Sales by Regions
2.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Flu Vaccine (Influenza Vaccine) Sales by Manufacturers
3.1.1 Flu Vaccine (Influenza Vaccine) Sales by Manufacturers
3.1.2 Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturers
3.1.3 Global Flu Vaccine (Influenza Vaccine) Market Concentration Ratio (CR5 and HHI)
3.2 Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers
3.2.1 Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2015-2020)
3.2.2 Flu Vaccine (Influenza Vaccine) Revenue Share by Manufacturers (2015-2020)
3.3 Flu Vaccine (Influenza Vaccine) Price by Manufacturers
3.4 Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution, Product Types
3.4.1 Flu Vaccine (Influenza Vaccine) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Flu Vaccine (Influenza Vaccine) Product Type
3.4.3 Date of International Manufacturers Enter into Flu Vaccine (Influenza Vaccine) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Flu Vaccine (Influenza Vaccine) Sales by Product
4.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Product
4.3 Flu Vaccine (Influenza Vaccine) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Flu Vaccine (Influenza Vaccine) Breakdown Data by End User
6 North America
6.1 North America Flu Vaccine (Influenza Vaccine) by Countries
6.1.1 North America Flu Vaccine (Influenza Vaccine) Sales by Countries
6.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Flu Vaccine (Influenza Vaccine) by Product
6.3 North America Flu Vaccine (Influenza Vaccine) by End User
7 Europe
7.1 Europe Flu Vaccine (Influenza Vaccine) by Countries
7.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales by Countries
7.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Flu Vaccine (Influenza Vaccine) by Product
7.3 Europe Flu Vaccine (Influenza Vaccine) by End User
8 Asia Pacific
8.1 Asia Pacific Flu Vaccine (Influenza Vaccine) by Countries
8.1.1 Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries
8.1.2 Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Flu Vaccine (Influenza Vaccine) by Product
8.3 Asia Pacific Flu Vaccine (Influenza Vaccine) by End User
9 Central & South America
9.1 Central & South America Flu Vaccine (Influenza Vaccine) by Countries
9.1.1 Central & South America Flu Vaccine (Influenza Vaccine) Sales by Countries
9.1.2 Central & South America Flu Vaccine (Influenza Vaccine) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Flu Vaccine (Influenza Vaccine) by Product
9.3 Central & South America Flu Vaccine (Influenza Vaccine) by End User
10 Middle East and Africa
10.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries
10.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries
10.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Product
10.3 Middle East and Africa Flu Vaccine (Influenza Vaccine) by End User
11 Company Profiles
11.1 CSL
11.1.1 CSL Company Details
11.1.2 Company Business Overview
11.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Flu Vaccine (Influenza Vaccine) Products Offered
11.1.5 CSL Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Flu Vaccine (Influenza Vaccine) Products Offered
11.2.5 GSK Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Products Offered
11.3.5 Sanofi Pasteur Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Business Overview
11.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Flu Vaccine (Influenza Vaccine) Products Offered
11.4.5 Mylan Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 Company Business Overview
11.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Flu Vaccine (Influenza Vaccine) Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Business Overview
11.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Flu Vaccine (Influenza Vaccine) Products Offered
11.6.5 Pfizer Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Company Business Overview
11.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Products Offered
11.7.5 Johnson & Johnson Recent Development
12 Future Forecast
12.1 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions
12.1.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Regions 2021-2028
12.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Regions 2021-2028
12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Product
12.2.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Product 2021-2028
12.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Product 2021-2028
12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by End User
12.4 North America Flu Vaccine (Influenza Vaccine) Forecast
12.5 Europe Flu Vaccine (Influenza Vaccine) Forecast
12.6 Asia Pacific Flu Vaccine (Influenza Vaccine) Forecast
12.7 Central & South America Flu Vaccine (Influenza Vaccine) Forecast
12.8 Middle East and Africa Flu Vaccine (Influenza Vaccine) Forecast
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Flu Vaccine (Influenza Vaccine) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.